Common use of Cancer package Clause in Contracts

Cancer package. o Chemotherapy and radiotherapy should be administered only by professionals trained in respective therapies (i.e. Medical Oncologists and Radiation Oncologists) and well versed with dealing with the side-effects the treatment can cause. o The Chemotherapy packages in Aarogyasri II are only supplementary to the packages in Aarogyasri I, hence they shall be used in association with Aarogyasri I packages. o Patients with hematological malignancies- (leukemia‟s, lymphoma‟s, multiple myeloma) and pediatric malignancies (Any patient < 14 years of age) should be treated by qualified medical oncologists only. o The advanced radiotherapy packages in Aarogyasri II shall be utilized only for the cases and diseases which do not respond to conventional radiotherapy package provided in Aarogyasri I. o Each cycle cost includes  Cost of chemotherapy drugs  Hospital charges  All the infusional chemotherapy cancer cases must be treated as inpatients only.  Doctors fees  Supportive care medications (i.e. i.v. fluids, steroids, H2 blockers, anti- emetics)  All Investigations o An average of Rs 2000 to Rs 5000/- has been added to the above cost, to cover for treatment of complications. o Tumors not included in this list, if have a chemotherapy regimen that is proven to be curative, or provide long term improvements in overall survival will be reviewed on a case by case basis by the technical committee of the Trust.

Cancer package. o Chemotherapy and radiotherapy should be administered only by professionals trained in respective therapies (i.e. Medical Oncologists and Radiation OncologistsOncolo- gists) and well versed with dealing with the side-effects the treatment can cause. o The Chemotherapy packages in Aarogyasri II are only supplementary to the packages in Aarogyasri I, hence they shall be used in association with Aarogyasri Aarogy- asri I packages. o Patients with hematological malignancies- (leukemia‟sleukemias, lymphoma‟slymphomas, multiple myelomamy- eloma) and pediatric malignancies (Any patient < 14 years of age) should be treated by qualified medical oncologists only. o The advanced radiotherapy packages in Aarogyasri II shall be utilized only for the cases and diseases which do not respond to conventional radiotherapy package pack- age provided in Aarogyasri I. o Each cycle cost includes  • Cost of chemotherapy drugs  • Hospital charges  • All the infusional chemotherapy cancer cases must be treated as inpatients inpa- tients only.  • Doctors fees  • Supportive care medications (i.e. i.v. fluids, steroids, H2 blockers, anti- emetics)  • All Investigations o An average of Rs 2000 to Rs 5000/- has been added to the above cost, to cover for treatment of complications. o Tumors not included in this list, if have a chemotherapy regimen that is proven to be curative, or provide long term improvements in overall survival surviv- al will be reviewed on a case by case basis by the technical committee of the Trust.

Cancer package. o Chemotherapy and radiotherapy should be administered only by professionals trained in respective therapies (i.e. Medical Oncologists and Radiation Oncologists) and well versed with dealing with the side-effects the treatment can cause. o The Chemotherapy packages in Aarogyasri II are only supplementary to the packages in Aarogyasri I, hence they shall be used in association with Aarogyasri I packages. o Patients with hematological malignancies- (leukemia‟sleukemia’s, lymphoma‟slymphoma’s, multiple myeloma) and pediatric malignancies (Any patient < 14 years of age) should be treated by qualified medical oncologists only. o The advanced radiotherapy packages in Aarogyasri II shall be utilized only for the cases and diseases which do not respond to conventional radiotherapy package provided in Aarogyasri I. o Each cycle cost includes  • Cost of chemotherapy drugs  • Hospital charges  • All the infusional chemotherapy cancer cases must be treated as inpatients only.  • Doctors fees  • Supportive care medications (i.e. i.v. fluids, steroids, H2 blockers, anti- emetics)  • All Investigations o An average of Rs 2000 to Rs 5000/- has been added to the above cost, to cover for treatment of complications. o Tumors not included in this list, if have a chemotherapy regimen that is proven to be curative, or provide long term improvements in overall survival will be reviewed on a case by case basis by the technical committee of the Trust.